Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant.
Ayalew TefferiAnimesh PardananiKebede H BegnaAref A Al-KaliWilliam Joseph HoganMark R LitzowRhett P KetterlingKaaren K ReichardNaseema GangatPublished in: Blood cancer journal (2024)